Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Toru Nemoto"'
Autor:
Toru Nemoto, Kennosuke Itoh, Hideaki Fujii, Takashi Iwai, Chiharu Iwamatsu, Mitsuo Tanabe, Eika Higashi, Shigeto Hirayama, Minami Nakamura
Publikováno v:
ACS Chemical Neuroscience. 10:2237-2242
The cyclopropylmethyl group in classical δ opioid receptor (DOR) antagonist NTI, BNTX, and NTB was replaced with various electron-withdrawing groups to develop DOR inverse agonists. N-Benzyl NTB derivative SYK-657 was a potent DOR full inverse agoni
Autor:
Don Operario, Toru Nemoto, Sari L. Reisner, Kristi E. Gamarel, Lynae A. Darbes, Colleen C. Hoff, Deepalika Chakravarty
Publikováno v:
AIDS Care. 28:104-111
Transgender women—individuals assigned a male sex at birth who identify as women, female, or on the male-to-female (MTF) trans feminine spectrum—are at high-risk of HIV worldwide. Prior research has suggested that transgender women more frequentl
Autor:
Shigeto Hirayama, Yusuke Iihara, Takashi Iwai, Hideaki Fujii, Toru Nemoto, Hiroshi Nagase, Eika Higashi
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 25:2927-2930
We synthesized derivatives of the δ opioid receptor (DOR) antagonists naltrindole (NTI) and compound 1 that were modified with small alkyl or fluorinated ethyl substituents on the 17-nitrogen. Although the derivatives showed decreased binding affini
Publikováno v:
ACS Medicinal Chemistry Letters. 5:868-872
We designed and synthesized the 1,3,5-trioxazatriquinane derivatives with m-hydroxyphenyl groups. These compounds include the phenethylamine structure within them, which is a common structure observed in morphinan derivatives like morphine. Among the
Autor:
Ryo Nakajima, Toru Nemoto, Naoshi Yamamoto, Hiroshi Nagase, Shigeto Hirayama, Hideaki Fujii, Takashi Iwai, Shuichi Hirono, Hiroaki Gouda
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 24(13):2851-2854
Indolopropellane 2 was reported to show almost no binding affinity to the δ opioid receptor (DOR) in spite of the fact that 2 has both the propellane fundamental skeleton (message part) with binding ability to the opioid receptors and a possible DOR
Autor:
Takashi Iwai, Hiroshi Nagase, Mitsuhiko Yamada, Akiyoshi Saitoh, Hideaki Fujii, Kohei Hayashida, Shigeto Hirayama, Toru Nemoto, Akinobu Yokoyama, Eriko Nakata, Yasuhito Uezono, Yuka Sudo
Publikováno v:
ACS Medicinal Chemistry Letters. 5:368-372
We synthesized compounds 4a,c-f,h,i containing the oxazatricyclodecane structure from a novel rearrangement reaction product 2a. All the prepared compounds 4a,c-f,h,i exhibited full agonistic activities for the δ opioid receptor (DOR). Among them, t
Autor:
Kyoko Ishikawa, Hideaki Fujii, Toru Nemoto, Kenichiro Nagai, Kennosuke Itoh, Shigeto Hirayama, Yusuke Mochizuki
Publikováno v:
Bioorganicmedicinal chemistry. 24(10)
As the reports about C-homomorphinans with the seven-membered C-ring are much fewer than those of morphinan derivatives with a six-membered C-ring, we attempted to synthesize C-homomorphinan derivatives and to evaluate their opioid activities. C-Homo
Autor:
Shigeto Hirayama, Hideaki Fujii, Hiroshi Nagase, Satomi Imaide, Shuichi Hirono, Hiroaki Gouda, Toru Nemoto
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 22:7711-7714
To clarify the essential structures of an opioid κ receptor selective agonist, nalfurafine, for binding to the κ receptor, we designed and synthesized the decahydro(iminoethano)phenanthrene derivatives with an oxygen functionality at the 3-position
Autor:
Hiroshi Nagase, Toru Nemoto, Shigeto Hirayama, Ryo Nakajima, Naoshi Yamamoto, Shuichi Hirono, Hiroaki Gouda, Hideaki Fujii, Junko Akiyama
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 22:7697-7701
Previously reported propellane derivative KNT-42 preferred the κ receptor and functioned as a message part in the message-address concept, but its affinity for the κ receptor was not high. To improve affinity, we synthesized five pentacyclic propel
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 22:5071-5074
To clarify the essential structures of an opioid κ receptor selective agonist, nalfurafine, for binding to the κ receptor, we designed and synthesized some nalfurafine derivatives and the decahydro(iminoethano)phenanthrene derivatives with a cycloh